<code id='25F62B1146'></code><style id='25F62B1146'></style>
    • <acronym id='25F62B1146'></acronym>
      <center id='25F62B1146'><center id='25F62B1146'><tfoot id='25F62B1146'></tfoot></center><abbr id='25F62B1146'><dir id='25F62B1146'><tfoot id='25F62B1146'></tfoot><noframes id='25F62B1146'>

    • <optgroup id='25F62B1146'><strike id='25F62B1146'><sup id='25F62B1146'></sup></strike><code id='25F62B1146'></code></optgroup>
        1. <b id='25F62B1146'><label id='25F62B1146'><select id='25F62B1146'><dt id='25F62B1146'><span id='25F62B1146'></span></dt></select></label></b><u id='25F62B1146'></u>
          <i id='25F62B1146'><strike id='25F62B1146'><tt id='25F62B1146'><pre id='25F62B1146'></pre></tt></strike></i>

          
          WSS
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          knowledge